risk factors for ACS
males > 45, females >55
smoking
HTN
known CAD
dyslipidemia
DM
chronic stable angina
lack of excerise
excessive ETOH
first degree relative w/ coronary event males before 55 females before 65
Drugs to give for ACS
Mona-GAP-BA
1st :morphine, O2, nitrates, ASA
2nd: GPIIb/IIIa, anticoags, P2Y12
within 24H: beta blockers, ACEi
P2Y12 inhibitors: prodrugs that irreversibly bind to receptor
clopidogrel and prasugrel
clopidogrel (Plavix) warnings
effectiveness depends on cyp 2C19 activity, contraindicated in active bleeds, TTP
prasugrel (Effient) warnings
dispense in original container, not recommended in pts > 75 unless high risk (MI, or DM), no not use if CABG, TTP
ticagrelor (Brilinta) warnings
after ASA loading dose, do not use ASA doses >100, avoid in CABG, severe hepatic impairment, bradyarrhythmias, TTP, increase uric acid, increase Scr
Plavix DDI
Avoid with cyp2C19 inhibitors eso and omeprazole
can increase effects of repaglinide which causes hypoglycemia
fibrinolytics MOA
fibrinolysis by binding to fibrin and converting plasminogen to plasmin
fibrinolytics MOA
Only for STEMI within 30 mins of arrival from door to needle